CardieX Limited (CDX.AX)

0,0510 -0,0040 (-7,27%) Börsenschluss: 02:27PM AEST

CardieX Limited

55 Lime Street
Suite 301 Level 3
Sydney, NSW 2000
Australia
61 2 9874 8761
https://cardiex.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD	Co-Founder & Executive Chairman	305,09k	N/A	1964
Mr. Craig R. Cooper BEC, L.L.B.	Co-Founder, Group CEO, MD & Executive Director	785,11k	N/A	1964
Dr. Ahmad Qasem Ph.D.	Chief Science & Research Officer	217,28k	N/A	1964
Dr. Steven Kesten	Chief Medical Officer	202,87k	N/A	1958
Dr. Mark Gorelick Ph.D.	Chief Product Officer	377,47k	N/A	1975
Ms. Catherine Liao	Chief Strategy Officer	361,38k	N/A	1979
Mr. Douglas T. Kurschinski	Executive VP & Head of Global Sales for AtCor Medical Division	342,61k	N/A	N/A
Ms. Louisa Ho	Company Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Corporate Governance

CardieX Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.